WuXi XDC Cayman Inc. is a leading global contract research, development and manufacturing organization focused on antibody drug conjugates and other bioconjugates. The company provides end-to-end services including discovery, process develo…
HQ: Wuxi, JS, People's Republic of Chinawuxixdc.com
HKD69.35-3.81%vs prev. close
Performance
1W
-1.77%
1M
-9.99%
3M
+11.76%
1Y
-2.05%
YTD
+11.58%
Valuation
P/E
56.4
EPS TTM
1.23
Dividend yield
—
Size and risk
Market cap
$11.2B
Beta
-0.75
Price history
2268.HK price
HKD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
WuXi XDC Cayman
2268.HK
Diagnostics & Research
Mkt cap (USD bn)
11.2
P/E
56.4
Div yld
—
1W
-1.8%
1M
-10.0%
3M
+11.8%
6M
+26.6%
1Y
-2.0%
YTD
+11.6%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
WuXi XDC Cayman
2268.HK
Diagnostics & Research
11.2
56.4
—
-1.8%
-10.0%
+11.8%
+26.6%
-2.0%
+11.6%
Subscribe to Equity Analytics to compare 2268.HK with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.